Ilya Goldshleger - Oct 4, 2024 Form 4 Insider Report for RxSight, Inc. (RXST)

Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Stock symbol
RXST
Transactions as of
Oct 4, 2024
Transactions value $
-$204,941
Form type
4
Date filed
10/8/2024, 06:00 PM
Previous filing
Sep 30, 2024
Next filing
Oct 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Options Exercise $46.7K +3.1K +7.34% $15.08 45.3K Oct 4, 2024 Direct
transaction RXST Common Stock Sale -$137K -2.87K -6.32% $47.96 42.5K Oct 4, 2024 Direct F1, F2
transaction RXST Common Stock Sale -$1.36K -28 -0.07% $48.47 42.5K Oct 4, 2024 Direct F1
transaction RXST Common Stock Sale -$10K -206 -0.49% $48.65 42.2K Oct 4, 2024 Direct F1
transaction RXST Common Stock Options Exercise $46.7K +3.1K +7.34% $15.08 45.3K Oct 8, 2024 Direct
transaction RXST Common Stock Sale -$150K -3.1K -6.84% $48.26 42.2K Oct 8, 2024 Direct F1, F3
holding RXST Common Stock 1.37K Oct 4, 2024 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXST Stock Option (right to buy) Options Exercise $0 -3.1K -3.11% $0.00 96.6K Oct 4, 2024 Common Stock 3.1K $15.08 Direct F4
transaction RXST Stock Option (right to buy) Options Exercise $0 -3.1K -3.21% $0.00 93.5K Oct 8, 2024 Common Stock 3.1K $15.08 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person.
F2 Represents the weighted average share price of an aggregate total of 2,866 shares sold in the price range of $47.37 to $48.33 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 3,100 shares sold in the price range of $48.02 to $48.81 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020.

Remarks:

Co-President and Chief Operating Officer